GR3006955T3 - - Google Patents

Info

Publication number
GR3006955T3
GR3006955T3 GR930400212T GR930400212T GR3006955T3 GR 3006955 T3 GR3006955 T3 GR 3006955T3 GR 930400212 T GR930400212 T GR 930400212T GR 930400212 T GR930400212 T GR 930400212T GR 3006955 T3 GR3006955 T3 GR 3006955T3
Authority
GR
Greece
Application number
GR930400212T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888814438A external-priority patent/GB8814438D0/en
Priority claimed from GB888824187A external-priority patent/GB8824187D0/en
Application filed filed Critical
Publication of GR3006955T3 publication Critical patent/GR3006955T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
GR930400212T 1988-06-17 1993-02-02 GR3006955T3 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888814438A GB8814438D0 (en) 1988-06-17 1988-06-17 Compounds for use in medicine
GB888824187A GB8824187D0 (en) 1988-10-14 1988-10-14 Compounds for use in medicine

Publications (1)

Publication Number Publication Date
GR3006955T3 true GR3006955T3 (https=) 1993-06-30

Family

ID=26294041

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400212T GR3006955T3 (https=) 1988-06-17 1993-02-02

Country Status (12)

Country Link
EP (1) EP0347243B1 (https=)
JP (1) JPH0240325A (https=)
KR (1) KR0158870B1 (https=)
AU (1) AU623147B2 (https=)
CA (1) CA1327524C (https=)
DE (1) DE68904358T2 (https=)
DK (1) DK299089A (https=)
ES (1) ES2045437T3 (https=)
GR (1) GR3006955T3 (https=)
HU (1) HU207220B (https=)
MY (1) MY106300A (https=)
PT (1) PT90888B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
CA2056039A1 (en) * 1991-01-22 1992-07-23 Philip L. Fuchs Carbacyclin analogs
US5190972A (en) * 1992-01-27 1993-03-02 The University Of Melbourne Method of combatting cyclosporine organ toxicity with prostaglandin analogs
KR100457499B1 (ko) * 1994-04-12 2005-02-23 도레이 가부시끼가이샤 폐성심질환치료제
EP0721783B1 (en) * 1994-06-07 2005-03-16 Toray Industries, Inc. Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung
US6046233A (en) * 1995-02-27 2000-04-04 Toray Industries, Inc. Agent for treating cor pulmonale
CN1224354A (zh) * 1997-02-27 1999-07-28 东丽株式会社 肺循环改善剂
US6521212B1 (en) * 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
EP1163333B1 (en) * 1999-03-18 2007-11-07 Queen Mary And Westfield College Inhibitors of endothelin-1 synthesis
BRPI0014869B8 (pt) 1999-10-15 2021-05-25 Sucampo Ag prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
US20090124697A1 (en) 2003-12-16 2009-05-14 United Therapeutics Corporation Inhalation formulations of treprostinil
CN1917866B (zh) 2003-12-16 2010-12-15 联合治疗公司 曲前列环素或它的衍生物，或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途
CA2678258A1 (en) * 2007-02-09 2008-08-14 United Therapeutics Corporation Treprostinil treatment for interstitial lung disease and asthma
CA2698721A1 (en) 2007-09-07 2009-03-12 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
IL252577B (en) 2014-12-03 2022-07-01 Steadymed Ltd Preservative-free treprostinil formulations and methods and devices for use with same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA787353B (en) * 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
DE3006865A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Hetero-imino-prostacycline
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
DE3315356A1 (de) * 1982-04-30 1983-11-17 Ono Pharmaceutical Co. Ltd., Osaka Verwendung von prostaglandinanalogen
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures

Also Published As

Publication number Publication date
DE68904358D1 (de) 1993-02-25
AU3652889A (en) 1989-12-21
HUT53524A (en) 1990-11-28
DE68904358T2 (de) 1993-07-29
PT90888B (pt) 1994-12-30
CA1327524C (en) 1994-03-08
PT90888A (pt) 1989-12-29
JPH0240325A (ja) 1990-02-09
KR0158870B1 (ko) 1998-12-01
AU623147B2 (en) 1992-05-07
EP0347243A1 (en) 1989-12-20
DK299089D0 (da) 1989-06-16
ES2045437T3 (es) 1994-01-16
EP0347243B1 (en) 1993-01-13
DK299089A (da) 1989-12-18
HU207220B (en) 1993-03-29
MY106300A (en) 1995-04-29
KR910000158A (ko) 1991-01-29

Similar Documents

Publication Publication Date Title
AU1273688A (https=)
AU1276388A (https=)
AU1432188A (https=)
AU1473588A (https=)
AU1476788A (https=)
AU1767888A (https=)
AU6860287A (https=)
AU7003687A (https=)
AU7442987A (https=)
AU7531787A (https=)
AU7677887A (https=)
AU7792787A (https=)
AU7839487A (https=)
AU7922587A (https=)
AU8228487A (https=)
AU8268587A (https=)
AU1095288A (https=)
AU1208388A (https=)
BG45083A1 (https=)
BG45242A1 (https=)
BG45476A1 (https=)
BG45076A1 (https=)
BG45077A1 (https=)
BG45081A1 (https=)
AU6708190A (https=)